French hospital studies an Impact of Containment and the Current Epidemic on the Sexual Risk-taking of People Using PrEP to Prevent HIV Infection

Photo by Matheus Ferrero

Tourcoing Hospital is enrolling patients into the clinical trial investigating Impact of Containment and the Current Epidemic on the Sexual Risk-taking of People Using PrEP to Prevent HIV Infection (CoroPrEP).

People using PrEP to prevent HIV infection have sexual risk-taking behaviors that motivated the prescription of PrEP. Both containment and the current epidemic may affect the sexual behavior of people using PrEP and the risk of acquiring STIs.

Hypotheses regarding the impact of the current epidemic-motivated confinement and its gradual lifting are as follows:

• A decrease in sexual risk-taking during the confinement period, followed by an increase when the confinement is lifted.
• An increase in sexual violence and the use of psychoactive substances.
• An impact on PrEP monitoring and compliance.
• An increase in the incidence of STIs when the confinement is lifted.

The trial is designed to enroll male and female 18 Years and older and is being conducted in the CH Tourcoing, Tourcoing, France.

The study start date is February 2021.

The study will be conducted in all persons using PrEP as prevention against HIV infection undergoing follow-up at Tourcoing Hospital and receiving counseling during months of inclusion.

Among the criteria that do not allow participation, the following are indicated:

• Minor patient
• Refusal to participate
• Trusteeship
• Curatorship

This page provides a more detailed overview of this clinical trial: https://ichgcp.net/clinical-trials-registry/NCT04772326